List Title | APhA DrugInfoLine

Psychiatry

SORT BY: Most Recent Most Viewed

July 30, 2018

Depression may result from adverse medication effects

READ

PREVIEW
A U.S. population–based survey conducted over a 10-year period showed that a little more than one-third of patients used medications that list depression as a potential adverse effect, and the...
July 16, 2018

Pharmacogenetic-based decision tools are not interchangeable

READ

PREVIEW
A comparison of four commercially available pharmacogenetic-based decision tools in patients with major depressive disorder (MDD) and numerous treatment failures showed that genotype and predicted...
June 26, 2018

Propranolol use in patients with posttraumatic stress disorder

READ

PREVIEW
Administration of propranolol 90 minutes before reactivation of traumatic memories resulted in significant reductions in posttraumatic stress disorder (PTSD) symptoms compared with placebo,...
April 16, 2018

New analysis compares efficacy and safety of antidepressants

READ

PREVIEW
Results of a systematic review and network meta-analysis involving 21 antidepressants (two not available in the United States) for acute treatment of adults with major depressive disorder (MDD)...
February 27, 2018

Pharmacogenetic-guided clozapine monitoring decisions shown to be cost effective

READ

PREVIEW
Genotype-guided blood sampling before clozapine initiation to guide monitoring decisions in patients with increased susceptibility to clozapine-induced agranulocytosis was shown to be cost...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.